Efalizumab-induced hypertrichosis
First published: 20 March 2008
No abstract is available for this article.
References
- 1
Dubertret L,
Sterry W,
Bos JD
et al.
CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial.
Br J Dermatol
2006; 155: 170–81.
- 2
Scheinfeld N.
Efalizumab: a review of events reported during clinical trials and side effects.
Expert Opin Drug Saf
2006; 5: 197–209.
- 3
Wendelin DS,
Pope DN,
Mallory SB.
Hypertrichosis.
J Am Acad Dermatol
2003; 48: 161–79.
- 4
Stenn KS,
Paus R.
Controls of hair follicle cycling.
Physiol Rev
2001; 81: 449–94.
